title: ATP metabolism in skeletal muscle arterioles.
abstract: The purpose of this study was to investigate the metabolism of Adenosine triphosphate (ATP) in skeletal muscle resistance arterioles and to determine whether this metabolism is altered during the rapid growth phase of the rat. We attempted to quantify ATP metabolism in gastrocnemius first-order arterioles from 8-, 10-, and 12-week-old rats. We measured ATP metabolism using an ATPase/GTPase assay with whole vessel segments as well as using a real-time adenosine biosensor following electric field stimulation. Our first method of measuring ATP metabolism allowed us to measure the amount of free phosphate produced with ATP as a substrate. When ecto-nucleotidase activity was inhibited by ARL67156, pyridoxal phosphate-6-azophenly-2', 4'-disulfonic acid (PPADS), or suramin prior to adding ATP, we found that the rate of phosphate production was significantly reduced by 27%, 21%, and 22%, respectively (P < 0.05). Our second method of measuring ATP metabolism allowed us to measure the amount of adenosine produced following electric field stimulation of the arteriole with and without nucleotidase inhibitors. Surprisingly, we found that adenosine overflow was not attenuated by nucleotidase inhibitors. We concluded that ecto-phosphodieterase/phyrophophatase (E-NPP), ecto-diadenosine polyphosphatase (ApnA), NTPDase1 and 2, and E5NT may be present on the gastrocnemius 1A arteriole and do play a role in ATP metabolism. Between the ages of 8 weeks and 12 weeks, however, overall ATP metabolism may not change.
authors.affiliation: Department of Health Science, Kinesiology, Recreation and Dance, University of Arkansas, Fayetteville, Arkansas ; Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
authors.forename: Audrey J
authors.initials: AJ
authors.lastname: Stone
authors.affiliation: Department of Health Science, Kinesiology, Recreation and Dance, University of Arkansas, Fayetteville, Arkansas.
authors.forename: Kirk W
authors.initials: KW
authors.lastname: Evanson
authors.affiliation: Department of Health Science, Kinesiology, Recreation and Dance, University of Arkansas, Fayetteville, Arkansas ; School of Kinesiology, Auburn University, Auburn, Alabama.
authors.forename: Heidi A
authors.initials: HA
authors.lastname: Kluess
keywords: Aging; development; ecto‐ATPase; neurotransmitter
references.citation: Am J Physiol Heart Circ Physiol. 2004 Feb;286(2):H633-9
references.pmid: 14551053
references.citation: Neurochem Int. 1998 May-Jun;32(5-6):421-5
references.pmid: 9676740
references.citation: J Physiol. 2007 Feb 15;579(Pt 1):115-25
references.pmid: 17082231
references.citation: Pharmacol Rep. 2008 Jan-Feb;60(1):12-20
references.pmid: 18276981
references.citation: Purinergic Signal. 2006 Jun;2(2):409-30
references.pmid: 18404480
references.citation: J Physiol. 2008 Sep 1;586(17):4305-16
references.pmid: 18617568
references.citation: Anal Chem. 2005 May 15;77(10):3267-73
references.pmid: 15889918
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):299-309
references.pmid: 11111825
references.citation: J Physiol. 2010 Oct 15;588(Pt 20):4017-27
references.pmid: 20807789
references.citation: Circ Res. 2008 Nov 7;103(10):1056-7
references.pmid: 18988902
references.citation: Braz J Med Biol Res. 2009 Jan;42(1):3-8
references.pmid: 18853040
references.citation: Nature. 2005 Jul 7;436(7047):108-11
references.pmid: 16001070
references.citation: Br J Pharmacol. 1996 Sep;119(1):1-2
references.pmid: 8872348
references.citation: Br J Pharmacol. 2007 Sep;152(1):141-50
references.pmid: 17603550
references.citation: Neuropharmacology. 2006 Feb;50(2):191-208
references.pmid: 16226282
references.citation: Physiol Res. 2001;50(4):411-7
references.pmid: 11551148
references.citation: J Physiol. 2002 Oct 1;544(Pt 1):161-70
references.pmid: 12356889
references.citation: Purinergic Signal. 2006 Jun;2(2):361-70
references.pmid: 18404476
references.citation: Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1302-10
references.pmid: 21784984
references.citation: J Pharmacol Exp Ther. 1980 Apr;213(1):85-90
references.pmid: 6244393
references.citation: Biochem J. 1986 Jan 15;233(2):309-19
references.pmid: 3006665
references.citation: Pharmacol Rev. 1998 Sep;50(3):413-92
references.pmid: 9755289
references.citation: BMC Genomics. 2010 Nov 30;11:675
references.pmid: 21118493
references.citation: Biochim Biophys Acta. 2000 Jun 1;1466(1-2):234-44
references.pmid: 10825445
references.citation: J Physiol. 2010 Aug 15;588(Pt 16):3089-100
references.pmid: 20566660
references.citation: J Neurosci. 2005 Feb 2;25(5):1211-8
references.pmid: 15689558
references.citation: J Physiol. 2011 May 15;589(Pt 10):2641-53
references.pmid: 21486772
references.citation: Neurochem Res. 2001 Sep;26(8-9):959-69
references.pmid: 11699948
references.citation: Circ Res. 2012 Jul 6;111(2):220-30
references.pmid: 22647875
references.citation: J Physiol. 1993 Apr;463:631-46
references.pmid: 8246199
references.citation: Br J Pharmacol. 2000 Nov;131(5):909-14
references.pmid: 11053210
references.citation: J Physiol. 1996 Nov 1;496 ( Pt 3):731-48
references.pmid: 8930840
references.citation: J Physiol. 2008 Aug 15;586(16):3963-78
references.pmid: 18617567
references.citation: J Endocrinol. 2012 May;213(2):123-41
references.pmid: 22396456
references.citation: Biochem Biophys Res Commun. 1991 Nov 14;180(3):1200-6
references.pmid: 1835387
references.citation: J Physiol. 2002 Oct 1;544(Pt 1):149-60
references.pmid: 12356888
references.citation: Am J Physiol. 1998 Apr;274(4):H1301-7
references.pmid: 9575935